Evidence map›Paper›PMID 28295042›Full record

ArticleScientific reports2017

Generation of non-viral, transgene-free hepatocyte like cells with piggyBac transposon.

Hokahiro Katayama, Kentaro Yasuchika, Yuya Miyauchi, Hidenobu Kojima, Ryoya Yamaoka, Takayuki Kawai, Elena Yukie Yoshitoshi, Satoshi Ogiso, Sadahiko Kita, Katsutaro Yasuda and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Hokahiro KatayamaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kentaro YasuchikaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yuya MiyauchiDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hidenobu KojimaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Ryoya YamaokaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takayuki KawaiDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Elena Yukie YoshitoshiDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Satoshi OgisoDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Sadahiko KitaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Katsutaro YasudaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Naoya SasakiDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Ken FukumitsuDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Junji KomoriDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takamichi IshiiDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Shinji UemotoDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Somatic cells can be reprogrammed to induced hepatocyte-like cells (iHeps) by overexpressing certain defined factors in direct reprogramming techniques. Of the various methods to deliver genes into cells, typically used genome-integrating viral vectors are associated with integration-related adverse events such as mutagenesis, whereas non-integrating viral vectors have low efficiency, making viral vectors unsuitable for clinical application. Therefore, we focused on developing a transposon system to establish a non-viral reprogramming method. Transposons are unique DNA elements that can be integrated into and removed from chromosomes. PiggyBac, a type of transposon, has high transduction efficiency and cargo capacity, and the integrated transgene can be precisely excised in the presence of transposase. This feature enables the piggyBac vector to achieve efficient transgene expression and a transgene-free state, thus making it a promising method for cell reprogramming. Here, we attempted to utilize the piggyBac transposon system to generate iHeps by integrating a transgene consisting of Hnf4a and Foxa3, and successfully obtained functional iHeps. We then demonstrated removal of the transgene to obtain transgene-free iHeps, which still maintained hepatocyte functions. This non-viral, transgene-free reprogramming method using the piggyBac vector may facilitate clinical applications of iHeps in upcoming cell therapy.

Indexed as

Genetic VectorsCellular ReprogrammingDNA Transposable ElementsGene Transfer TechniquesHepatocytesHumansTransgenesTransposasesDNA Transposable ElementsTransposases

Identifiers

PMID28295042
PMCPMC5353749
OpenAlexW2605358760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.